Cargando…

Cell based therapy in Parkinsonism

Parkinson’s disease (PD) is a synucleinopathy-induced chronic progressive neurodegenerative disorder, worldwide affecting about 5 million humans. As of yet, actual therapies are symptomatic, and neuroprotective strategies are an unmet need. Due to their capability to transdifferentiate, to immune mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Munter, Johannes PJM, Lee, Chongsik, Wolters, Erik Ch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674952/ https://www.ncbi.nlm.nih.gov/pubmed/23734727 http://dx.doi.org/10.1186/2047-9158-2-13

Ejemplares similares

Neuro‐Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice
por: de Munter, Johannes P.J.M., et al.
Publicado: (2019)

Treatment of rats with spinal cord injury using human bone marrow-derived stromal cells prepared by negative selection
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2020)

Why do anti-inflammatory signals of bone marrow-derived stromal cells improve neurodegenerative conditions where anti-inflammatory drugs fail?
por: de Munter, J. P. J. M., et al.
Publicado: (2020)

Tauroursodeoxycholic Acid Reduces Neuroinflammation but Does Not Support Long Term Functional Recovery of Rats with Spinal Cord Injury
por: Wu, Siyu, et al.
Publicado: (2022)

Chaperone-Based Therapies for Disease Modification in Parkinson's Disease
por: Friesen, Erik L., et al.
Publicado: (2017)

Molecular and behavioural abnormalities in the FUS‐tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti‐inflammatory therapies
por: de Munter, Johannes, et al.
Publicado: (2020)

Cell based therapies in Parkinson’s Disease
por: Behari, Madhuri, et al.
Publicado: (2011)

Stem Cell-Based Therapies for Parkinson Disease
por: Liu, Zhaohui, et al.
Publicado: (2020)

Development of stem cell-based therapy for Parkinson’s disease
por: Han, Fabin, et al.
Publicado: (2015)

Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled study
por: Deijen, Jan Berend, et al.
Publicado: (2006)

Gene and Cell-Based Therapies for Parkinson’s Disease: Where Are We?
por: Buttery, Philip C., et al.
Publicado: (2020)

Cell Therapy for Parkinson’s Disease
por: MORIZANE, Asuka, et al.
Publicado: (2016)

Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease
por: Chou, Chung-Hsing, et al.
Publicado: (2015)

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy
por: Kitada, Masaaki, et al.
Publicado: (2012)

Metabolic Basis of Circadian Dysfunction in Parkinson’s Disease
por: Rathor, Priya, et al.
Publicado: (2023)

Stem cell transplantation therapy in Parkinson’s disease
por: Fu, Mu-Hui, et al.
Publicado: (2015)

Defining the unknowns for cell therapies in Parkinson's disease
por: Lane, Emma L., et al.
Publicado: (2022)

Prospect of cell therapy for Parkinson's disease
por: Pawitan, Jeanne Adiwinata
Publicado: (2011)

A Stage-Based Approach to Therapy in Parkinson’s Disease
por: Carrarini, Claudia, et al.
Publicado: (2019)

Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells
por: Rodríguez-Pallares, Jannette, et al.
Publicado: (2022)

Aberrant Ganglioside Functions to Underpin Dysregulated Myelination, Insulin Signalling, and Cytokine Expression: Is There a Link and a Room for Therapy?
por: Svirin, Evgeniy, et al.
Publicado: (2022)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Stem cell therapy for Parkinson’s disease: safety and modeling
por: Stoddard-Bennett, Theo, et al.
Publicado: (2019)

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
por: Cha, Young, et al.
Publicado: (2023)

Therapy of Parkinson's Disease
por: Holzer, Jacob C.
Publicado: (1990)

Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies
por: Rocha, Natália Pessoa, et al.
Publicado: (2015)

Drug therapy in patients with Parkinson’s disease
por: Müller, Thomas
Publicado: (2012)

Gene Therapy for Parkinson’s Disease, An Update
por: Axelsen, Tobias M., et al.
Publicado: (2018)

CDNF Protein Therapy in Parkinson’s Disease
por: Huttunen, Henri J., et al.
Publicado: (2019)

Novel targeted therapies for Parkinson’s disease
por: Ntetsika, Theodora, et al.
Publicado: (2021)

Infusion Therapies in the Treatment of Parkinson’s Disease
por: van Laar, Teus, et al.
Publicado: (2023)

The role of nonhuman primate models in the development of cell-based therapies for Parkinson’s disease
por: Vermilyea, Scott C., et al.
Publicado: (2017)

Gene Therapy for Parkinson's Disease
por: Denyer, Rachel, et al.
Publicado: (2012)

Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
por: Titze-de-Almeida, Simoneide Souza, et al.
Publicado: (2023)

Potential sources of stem cells as a regenerative therapy for Parkinson’s disease
por: El-Sadik, Abir Oueida
Publicado: (2010)

Improved Delivery Methods for Gene Therapy and Cell Transplantation in Parkinson’s Disease
por: Larson, Paul S.
Publicado: (2021)

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023)

The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease
por: Zhang, Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4ndj02v6ob0tv4kaoelqlid327